Senators grilled the top executive of NovoNordisk over why the Danish company charges Americans far more for the blockbuster weight-loss drug Wegovy and diabetes drug Ozempic than it does ...
Drugmaker is pressed to cut prices for its blockbuster diabetes and obesity drugs The CEO of NovoNordisk faced pointed questions about the cost of Ozempic and Wegovy on Capitol Hill Tuesday ...
Ozempic maker NovoNordisk on Wednesday said data showed its hotly anticipated weight loss pill prompts greater and more rapid weight loss than its blockbuster treatment Wegovy, amid competition ...